Unknown PHASE3 INTERVENTIONAL 2-arm NCT02461264

Transfusion Strategy in Hematological Intensive Care Unit (1VERSUS2CGR)

Randomized Multicenter Trial of Two Transfusion Strategies for Patient Receiving Chemotherapy for Acute Leukemia or Hematopoietic Stem Cells With Medico-economic Evaluation of Cost Minimization.

Sponsor: University Hospital, Caen

Conditions Transfusion Related Complication

Interventions Single red blood packed cells Transfusion Two packed red blood cells Transfusion

Updated 8 times since 2017 Last updated: Apr 18, 2019 Started: Jan 31, 2016 Primary completion: Jun 30, 2019 Completion: Sep 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Transfusion Related Complication, this trial is ongoing. The trial is conducted by University Hospital, Caen and has accumulated 8 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting PHASE3
May 2019 — Jan 2021 [monthly]

Recruiting PHASE3

Status: Unknown Status → Recruiting

▶ Show 3 earlier versions

Oct 2018 — May 2019 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jun 2018 — Oct 2018 [monthly]

Recruiting PHASE3
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Caen

Data source: University Hospital, Caen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Caen, France